Skip to content

Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers

Rapid Acceleration of Diagnostics Underserved Populations Supplement: Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05812599
Enrollment
298
Registered
2023-04-13
Start date
2022-09-22
Completion date
2023-01-20
Last updated
2023-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Communication, Health Knowledge, Attitudes, Practice

Brief summary

The purpose of this study is to identify promising health education strategies and culturally appropriate messages for use by 2-1-1 practitioners to promote coronavirus disease of 2019 (COVID) testing behaviors. Previous study findings and evidence-based health communication and education tactics were integrated to create an interactive learning module that includes four narrative scenarios, illustrations, and accompanying questions and responses that inform the audience about COVID testing guidelines. The study will test the effectiveness of the interactive learning module with 2-1-1 callers (n=300) in Connecticut, North Carolina, and Nebraska. Participants' contact information will be shared with us by 2-1-1 with the participants' given consent. The study team will send the potential participant via text message a link to a survey that includes a screen where they will provide informed consent. Those who provide consent will be randomly assigned to receive one of two surveys. The inclusion of the interactive learning module is what varies across the surveys. An experimental group will receive the learning module with a study team-developed pre- and post-survey, and the control group will receive only the study team-developed pre- and post-survey. The post-survey contains questions regarding information covered in the interactive learning module. It is hypothesized that those who complete the interactive learning module in the experimental group will score better on the post-survey questions when compared to the control group. All participants, regardless of experimental or control condition, will receive an information sheet with the most up-to-date scientific guidelines for COVID testing.

Interventions

The COVID Test Learning Module will present four multi-part character scenarios that someone might experience when considering testing for COVID-19. Participants will answer questions about the character's behavior. Accurate guidelines will be provided in response to each scenario to educate participants about what to do in nuanced COVID testing decision-making situations.

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Individuals who called 211 in Connecticut, Nebraska, or North Carolina on behalf of themselves or their families * Must be 18 or older * Must have English language proficiency * Must be willing to be contacted via text messages or email

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants who answer post-test questions correctlyThrough survey completion, an average of 10-15 minutes.The primary objective of this study is to evaluate differences in knowledge regarding COVID testing between 2-1-1 callers randomized to the control vs. experimental group. Participants who do better would answer more items correctly on the COVID prevention knowledge post-test. Assessed using a non-parametric t-test.

Secondary

MeasureTime frameDescription
Number of participants with knowledge gained after exposure to learning moduleThrough survey completion, an average of 10-15 minutes.A secondary outcome is to identify if exposure to the learning module increased participant knowledge about COVID prevention. Assessed by comparing the percentage of correct answers from questions within the learning module to the percentage of correct answers in the post-test.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026